🚀 VC round data is live in beta, check it out!
Dallah Healthcare Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dallah Healthcare and similar public comparables like Medicover, Kpj Healthcare, Asker Healthcare Group, Global Health and more.
Dallah Healthcare Overview
About Dallah Healthcare
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Services/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.
Founded
1994
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$4B
Dallah Healthcare Financials
Dallah Healthcare reported last 12-month revenue of $1B and EBITDA of $232M.
In the same LTM period, Dallah Healthcare generated $232M in EBITDA and $142M in net income.
Revenue (LTM)
Dallah Healthcare P&L
In the most recent fiscal year, Dallah Healthcare reported revenue of $856M and EBITDA of $200M.
Dallah Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $856M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $322M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 38% | XXX | XXX | XXX |
| EBITDA | $232M | XXX | $200M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 23% | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 18% | XXX | XXX | XXX |
| Net Profit | $142M | XXX | $126M | XXX | XXX | XXX |
| Net Margin | 13% | XXX | 15% | XXX | XXX | XXX |
| Net Debt | — | — | $462M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Dallah Healthcare Stock Performance
Dallah Healthcare has current market cap of $3B, and enterprise value of $4B.
Market Cap Evolution
Dallah Healthcare's stock price is $34.11.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $3B | 0.0% | XXX | XXX | XXX | $1.24 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDallah Healthcare Valuation Multiples
Dallah Healthcare trades at 3.9x EV/Revenue multiple, and 18.6x EV/EBITDA.
EV / Revenue (LTM)
Dallah Healthcare Financial Valuation Multiples
As of April 18, 2026, Dallah Healthcare has market cap of $3B and EV of $4B.
Equity research analysts estimate Dallah Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dallah Healthcare has a P/E ratio of 24.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 3.9x | XXX | 5.0x | XXX | XXX | XXX |
| EV/EBITDA | 18.6x | XXX | 21.5x | XXX | XXX | XXX |
| EV/EBIT | 25.2x | XXX | 27.5x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 13.4x | XXX | XXX | XXX |
| P/E | 24.3x | XXX | 27.4x | XXX | XXX | XXX |
| EV/FCF | (910.8x) | XXX | 51.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dallah Healthcare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Dallah Healthcare Margins & Growth Rates
Dallah Healthcare's revenue in the last 12 month grew by 8%.
Dallah Healthcare's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dallah Healthcare's rule of X is 42% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Dallah Healthcare Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | 14% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 42% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Dallah Healthcare Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Dallah Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Medicover | XXX | XXX | XXX | XXX | XXX | XXX |
| Kpj Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Asker Healthcare Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Global Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Aster DM Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dallah Healthcare M&A Activity
Dallah Healthcare acquired XXX companies to date.
Last acquisition by Dallah Healthcare was on XXXXXXXX, XXXXX. Dallah Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Dallah Healthcare
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDallah Healthcare Investment Activity
Dallah Healthcare invested in XXX companies to date.
Dallah Healthcare made its latest investment on XXXXXXXX, XXXXX. Dallah Healthcare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Dallah Healthcare
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dallah Healthcare
| When was Dallah Healthcare founded? | Dallah Healthcare was founded in 1994. |
| Where is Dallah Healthcare headquartered? | Dallah Healthcare is headquartered in Saudi Arabia. |
| Is Dallah Healthcare publicly listed? | Yes, Dallah Healthcare is a public company listed on Tadawul. |
| What is the stock symbol of Dallah Healthcare? | Dallah Healthcare trades under 4004 ticker. |
| When did Dallah Healthcare go public? | Dallah Healthcare went public in 2012. |
| Who are competitors of Dallah Healthcare? | Dallah Healthcare main competitors are Medicover, Kpj Healthcare, Asker Healthcare Group, Global Health. |
| What is the current market cap of Dallah Healthcare? | Dallah Healthcare's current market cap is $3B. |
| What is the current revenue of Dallah Healthcare? | Dallah Healthcare's last 12 months revenue is $1B. |
| What is the current revenue growth of Dallah Healthcare? | Dallah Healthcare revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Dallah Healthcare? | Current revenue multiple of Dallah Healthcare is 3.9x. |
| Is Dallah Healthcare profitable? | Yes, Dallah Healthcare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dallah Healthcare? | Dallah Healthcare's last 12 months EBITDA is $232M. |
| What is Dallah Healthcare's EBITDA margin? | Dallah Healthcare's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Dallah Healthcare? | Current EBITDA multiple of Dallah Healthcare is 18.6x. |
| What is the current FCF of Dallah Healthcare? | Dallah Healthcare's last 12 months FCF is ($5M). |
| What is Dallah Healthcare's FCF margin? | Dallah Healthcare's last 12 months FCF margin is (0%). |
| What is the current EV/FCF multiple of Dallah Healthcare? | Current FCF multiple of Dallah Healthcare is (910.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.